https://doctransparency.com/doctor/tx/san-antonio/daniel-saltzstein-1922088947
Medicare Enrolled

Dr. Daniel Saltzstein, MD

Surgery · San Antonio, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
18915 MEISNER DR, San Antonio, TX 78258
2104995158
In practice since 2006 (20 years)
NPI: 1922088947 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saltzstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saltzstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saltzstein

Dr. Daniel Saltzstein is a surgery in San Antonio, TX, with 20 years in practice. Based on federal Medicare data, Dr. Saltzstein performed 19,766 Medicare services across 5,207 unique beneficiaries.

Between the years covered by Open Payments, Dr. Saltzstein received a total of $597,616 from 50 pharmaceutical and/or device companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saltzstein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 0% volume in TX$ $597,616 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,766
Medicare services
Top 0% in TX for surgery
5,207
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~988 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)10,320$18$31
Infectious disease DNA/RNA test1,608$34$78
Urinalysis with microscopic exam1,260$3$15
Office visit, established patient (30-39 min)1,062$87$215
Bladder ultrasound after voiding900$7$95
PSA test (prostate cancer screening)864$18$110
Chronic care management, first 20 min/month787$40$80
Testosterone (hormone) level, total501$25$150
Office visit, established patient (20-29 min)290$57$150
Basic metabolic blood panel198$8$45
Blood draw (venipuncture)152$8$10
Leuprolide acetate (for depot suspension), 7.5 mg150$131$700
Complete blood count (CBC), automated145$6$25
Yeast/candida DNA test133$34$78
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique133$34$78
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique132$34$78
Diagnostic exam of bladder and urethra using an endoscope124$178$490
Liver function blood test panel107$8$45
New patient office visit (45-59 min)105$116$313
Drug injection, under skin or into muscle91$10$30
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle91$23$75
New patient office visit (30-44 min)57$78$210
Hospital follow-up visit, low complexity56$36$90
Red blood cell concentration measurement50$2$8
Blood count, hemoglobin50$2$8
Complete blood count (CBC) with differential38$8$25
Office visit, established patient, complex (40-54 min)38$127$290
Psa (prostate specific antigen) measurement, free37$18$150
Analysis for detection of tumor marker37$20$115
Initial hospital admission, moderate complexity32$97$275
Blood creatinine level27$5$20
Urea nitrogen level to assess kidney function, quantitative27$4$20
Ct scan of abdomen and pelvis before and after contrast25$229$700
Cell examination of specimen, selective cellular enhancement technique25$29$210
Simple bladder irrigation and/or instillation19$50$215
Crushing of stone of ureter with insertion of stent using an endoscope15$312$2,000
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method15$125$685
Simple insertion of temporary bladder tube14$43$180
Insertion of stent in ureter using an endoscope14$90$1,286
Chronic care management, additional 20 min/month13$33$92
Biopsy of prostate gland12$97$350
Ultrasound scan of pelvic region through rectum12$25$285
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
58.0% medium
41.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$597,616
Total received (2018-2024)
Avg $85,374/year across 7 years
Top 0% in TX for surgery
50
Companies
761
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$422,789 (70.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$171,110 (28.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,717 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65,868
2023
$83,631
2022
$100,767
2021
$92,138
2020
$60,526
2019
$89,343
2018
$105,344

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$132,433
Astellas Pharma US Inc
$84,925
Myovant Sciences Inc.
$67,589
Janssen Scientific Affairs, LLC
$49,428
SN Holdings, LLC
$39,023
Bayer HealthCare Pharmaceuticals Inc.
$32,167
Bayer Healthcare Pharmaceuticals Inc.
$30,825
UroGPO LLC
$25,645
Dendreon Pharmaceuticals LLC
$19,881
Sumitomo Pharma America, Inc.
$18,774
Progenics Pharmaceuticals, Inc.
$15,161
PFIZER INC.
$14,195
AstraZeneca Pharmaceuticals LP
$9,993
NOVARTIS PHARMACEUTICALS CORPORATION
$9,347
Astellas Pharma Global Development
$9,115
Sun Pharmaceutical Industries Inc.
$4,324
TOLMAR Pharmaceuticals, Inc.
$4,197
Novartis Pharmaceuticals Corporation
$4,037
UROGEN PHARMA, INC.
$3,994
Foundation Medicine, Inc.
$3,852
Clovis Oncology, Inc.
$3,145
Merck Sharp & Dohme Corporation
$3,074
Ferring Pharmaceuticals Inc.
$2,216
Amgen Inc.
$2,104
Exelixis Inc.
$1,980
Blue Earth Diagnostics Limited
$1,605
E.R. Squibb & Sons, L.L.C.
$850
Telix Pharmaceuticals
$794
ACCORD HEALTHCARE, INC.
$763
Verity Pharmaceuticals Inc.
$750
Merck Sharp & Dohme LLC
$181
Axonics, Inc.
$177
AbbVie, Inc.
$163
UroGen Pharma, Inc.
$138
Endo Pharmaceuticals Inc.
$102
Janssen Products, LP
$99
Allergan Inc.
$97
ABBVIE INC.
$70
GENZYME CORPORATION
$68
Tolmar, Inc.
$67
Mission Pharmacal Company
$50
UROVANT SCIENCES INC
$37
Antares Pharma, Inc.
$36
Myriad Genetic Laboratories, Inc.
$34
PROCEPT BioRobotics Corporation
$24
AbbVie Inc.
$21
Supernus Pharmaceuticals, Inc.
$19
Retrophin, Inc.
$17
Cook Medical LLC
$17
Acerus Pharmaceuticals Corporation
$12
Top 3 companies account for 47.7% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AKEEGA · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CABOMETYX · CAMCEVI · Cook Medical Extractors · DARZALEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE CDX · GEMTESA · ILLUCCIX · IMFINZI · JELMYTO · JEVTANA · KEYTRUDA · LYNPARZA · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Natesto · Non-Covered · Nubeqa · ORGOVYX · Otrexup · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · RUBRACA · Rubraca · SUTENT · TLANDO · TOVIAZ · Trelstar · URIBEL · Uribel · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgery and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for surgery in TX.

Equivalent to $3,023 per 100 Medicare services performed
Looking for a surgery in San Antonio?
Compare surgerys in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse surgerys nearby

Geographic Context

Surgerys within 10 mi
275
Per 100K population
13.5
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Saltzstein is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (speaking/promotional, top 0%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Saltzstein experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Saltzstein performed 10,320 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Saltzstein receive payments from pharmaceutical companies?
Yes. Dr. Saltzstein received a total of $597,616 from 50 companies across 761 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saltzstein's costs compare to other surgerys in San Antonio?
Dr. Saltzstein's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saltzstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →